These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29626315)

  • 41. Polyphenols for the Prevention and Treatment of Cognitive Impairment.
    Yamada M
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S121-S124. PubMed ID: 36436991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Potential Role of Vitamin D Supplementation in Cognitive Impairment Prevention.
    Zeqaj I; Piffero R; Calzaducca E; Pirisi M; Bellan M
    CNS Neurol Disord Drug Targets; 2024; 23(5):628-637. PubMed ID: 36998124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review.
    Janoutová J; Šerý O; Hosák L; Janout V
    Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can We Treat Neuroinflammation in Alzheimer's Disease?
    Sánchez-Sarasúa S; Fernández-Pérez I; Espinosa-Fernández V; Sánchez-Pérez AM; Ledesma JC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease.
    Sattler C; Toro P; Schönknecht P; Schröder J
    Psychiatry Res; 2012 Mar; 196(1):90-5. PubMed ID: 22390831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.
    Koenig AM; Mechanic-Hamilton D; Xie SX; Combs MF; Cappola AR; Xie L; Detre JA; Wolk DA; Arnold SE
    Alzheimer Dis Assoc Disord; 2017; 31(2):107-113. PubMed ID: 28538088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes.
    Palleria C; Leporini C; Maida F; Succurro E; De Sarro G; Arturi F; Russo E
    Front Neuroendocrinol; 2016 Jul; 42():76-92. PubMed ID: 27521218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs.
    Pramanik R; Dey A; Chakrabarty AK; Banerjee D; Narwaria A; Sharma S; Rai RK; Katiyar CK; Dubey SK
    J Ethnopharmacol; 2024 Oct; 333():118402. PubMed ID: 38821139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.
    Tramutola A; Arena A; Cini C; Butterfield DA; Barone E
    Expert Rev Neurother; 2017 Jan; 17(1):59-75. PubMed ID: 27715341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
    Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
    Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
    Prickaerts J; Heckman PRA; Blokland A
    Expert Opin Investig Drugs; 2017 Sep; 26(9):1033-1048. PubMed ID: 28772081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Matsunaga S; Kishi T; Annas P; Basun H; Hampel H; Iwata N
    J Alzheimers Dis; 2015; 48(2):403-10. PubMed ID: 26402004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Molecular pathogenesis and development of disease-modifying drugs for Alzheimer's disease].
    Takeda M
    Seishin Shinkeigaku Zasshi; 2013; 115(1):32-40. PubMed ID: 23691792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.